(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

DOUBLEMIN

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

DOUBLEMIN

ST13

US500000079272122

Class

5

Filing

79272122

Registration

6026278

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

15

Latest update

04/10/2023

Trademark type

Word

Nice classes

5

Filing date

09/10/2019

Registration date

04/07/2020

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

04/07/2020

Last transaction

04/07/2020

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

03

Owner location

JP

Examiner

SMITH, CYNTHIA RINALDI

Law office

L70

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

KOWA COMPANY, LTD.

Representatives

TAKANO Toshio, The Patent Corporate Body Aruga

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparations for the treatment of conditions and diseases of the central nervous systemthe peripheral nervous systemthe sensory organsthe circulatory systemthe respiratory systemthe digestive system; pharmaceutical preparations comprising hormones; pharmaceutical preparations for the treatment of urogenital or anal conditions; pharmaceutical preparations for the treatment of dermatological conditions; pharmaceutical preparations comprising vitamins and amino acids; pharmaceutical preparations for the treatment of blood conditions and metabolic conditions; pharmaceutical preparations for treating tumors and lesions; pharmaceutical preparations comprising antibiotics; pharmaceutical preparations for treating medical conditions caused by parasites; pharmaceutical preparations comprising labeled isotopes; pharmaceutical preparations comprising narcotics; preparations for destroying verminfungicidesherbicides; reagent paper for medical purposes; oiled paper for medical purposes; wrapping wafers for dosing of medicine; gauze for dressings; empty capsules for pharmaceuticals; eye patches for medical purposes; ear bandages; menstruation bandages; menstruation tampons; sanitary napkins; sanitary panties; absorbent cotton for medical purposes; adhesive plasters for medical purposes; bandages for dressings; antiseptic liquid dressings; breast- nursing pads; dietary supplements for humans; dietetic beverages adapted for medical purposes; dietetic food adapted for medical purposes

Publications

History of USPTO decisions and trademark events.

15 publications found

NREP

NEW REPRESENTATIVE AT IB RECEIVED

04/10/2023

RNWL

INTERNATIONAL REGISTRATION RENEWED

12/05/2022

GPNX

NOTIFICATION PROCESSED BY IB

06/19/2020

FICS

FINAL DISPOSITION NOTICE SENT TO IB

05/27/2020

FIMP

FINAL DISPOSITION PROCESSED

05/26/2020

GPAR

GRANT OF PROTECTION CREATED, TO BE SENT TO IB

05/07/2020

R.PR

REGISTERED-PRINCIPAL REGISTER

04/07/2020

PUBO

PUBLISHED FOR OPPOSITION

01/21/2020

NPUB

NOTICE OF PUBLICATION

01/01/2020

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

12/13/2019

DOCK

ASSIGNED TO EXAMINER

12/11/2019

MAFR

APPLICATION FILING RECEIPT MAILED

11/26/2019

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

11/22/2019

LIMI

LIMITATION FROM ORIGINAL APPLICATION ENTERED

11/19/2019

SDRC

SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB

11/14/2019

Continuous trademark protection

Get notified about every new filing that threatens DOUBLEMIN or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.